Interpretation of laboratory results for COVID-19 diagnosis, 6 May 2020
Gov't Doc #
MetadataShow full item record
Other Language Versions
Etiological confirmation of COVID-19 virus (SARS-CoV-2) infection can only be made by laboratory tests. In general, the currently available assays for COVID-19 can be classified into two groups: • The first group (virological tests) includes tests that can detect the presence of the components of the virus (genetic material or antigens). These tests can confirm the diagnosis of patients with symptoms compatible with COVID-19, detect infections in populations with high-risk of infection (such as health workers) or severity (hypertension, diabetes, obesity, cardiovascular history, chronic respiratory, immunosuppression, cancer, etc.), and assess whether an individual recovered from COVID-19 may still be infectious. • The second group of tests (serological) detects antibodies (IgM or IgG) generated as part of the individual's immune response against the SARS-CoV-2 virus, that is, they indicate previous or ongoing contact. The immunity (protection) conferred by the antibodies is still under investigation. Once sufficient evidence is available, serological tests would be, together with direct virus detection, an essential tool in the development of strategies that allow relaxation of current public health measures.
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO
Showing items related by title, author, creator and subject.
Pan American Health Organization; Health Emergencies (PHE) (Washington, D.C., PAHO, 2020-03-30)Coronaviruses are a group of highly diverse RNA viruses in the Coronaviridae family that are divided in 4 genera: alpha, beta, gamma and delta that cause disease varying from mild to severe in human and animals (1-3). There ...
Interim laboratory biosafety guidelines for the handling and transport of samples associated with the novel coronavirus 2019 (2019-nCoV), 28 January 2020 Pan American Health Organization; Health Emergencies (PHE) (Washington, D.C., PAHO, 2020-01-28)In January 2020, the etiologic agent responsible for a cluster of severe pneumonia cases in Wuhan, China, was identified as a novel beta-coronavirus (2019-nCoV), distinct than SARS-CoV and MERS-CoV (1) (2) (3). The complete ...
Pan American Health Organization; Health Emergencies (PHE) (Washington, D.C., PAHO, 2020-02-01)Coronaviruses are a group of highly diverse RNA virus in the Coronaviridae family that are divided in 4 genera: alpha, beta, gamma and delta that cause disease varying from mild to severe in human and animals. There are ...